Project Grant R01HD115359

Award Date 7/18/24
Completion Date 4/30/29
Dollars Obligated $3.4M
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Kansas City, MO 64108, USA
Similar Awards
This federal Project Grant award of $1,802,392.00 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to improve the identification of genetic contributors to rare neurodevelopmental disorders in children. The funding will support sequencing the genomes of 500 affected individuals, along with 200 of their parents, using Pacific Biosciences' "HiFi" long-read DNA sequencing...
The National Institute of Child Health and Human Development (NICHD) awarded a $2,442,535 five-year Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Harvard Pilgrim Health Care Inc. to investigate the long-term impact and value of implementing newborn genomic sequencing. The project aims to provide critical evidence on how to effectively implement newborn genomic sequencing, manage the resulting findings, and reanalyze data over time to ensure it provides...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is focused on developing epigenomic liquid biopsy methods for early detection and prediction of preterm birth, preeclampsia, and intrauterine growth restriction. The total grant award of $717,871 to the Magee-Womens Research Institute and Foundation aims to create non-invasive screening tools to...
This $153,252 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to develop strategies for identifying individuals at high risk for genetic diseases in order to enable earlier diagnosis and treatment. The award has two key aims: 1) Reevaluating guidelines for universal preconception carrier screening to improve uptake and include new actionable...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) is focused on generating strategies and resources to facilitate informed decision-making for pregnant patients regarding prenatal genetic screening and diagnostic tests (PS&D). The $831,046 award, effective September 18, 2024 through August 31, 2025, aims to: Determine how changes in PS&D and post-diagnosis options affect the resources and support patients need for informed...
This Project Grant award of $311,000 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund the development of comprehensive de novo variant (DNV) callsets for the Gabriella Miller Kids First Pediatric Research Program's birth defects dataset. The key products to be delivered under this 2-year award include: 1) Identification of new genes involved in birth defects through the...
The National Institute of General Medical Sciences (NIGMS) awarded a $445,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Children's Hospital of Philadelphia (CHOP) to develop long-read RNA sequencing technologies and apply them to advancing genomic medicine. The central objective is to harness long-read transcriptomics to elucidate transcriptome complexity and identify therapeutic targets for rare and complex diseases. The 5-year project aims to: 1) develop...
This $400,000 Project Grant award from the National Human Genome Research Institute (NHGRI) under CFDA 93.172 "Human Genome Research" will support a research program at Brigham & Women's Hospital to develop advanced computational methods for accurately identifying and genotyping structural variants within large genetic biobank datasets. The key objectives of the work are to: 1) create haplotype-informed algorithms to improve detection sensitivity and genotyping accuracy for...
This Project Grant award, valued at $293,756, was provided by the National Institutes of Health (NIH) under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the Institute for Systems Biology (ISB). The funding will support research to enhance understanding of placental dysfunction in common obstetric disorders like preeclampsia, preterm birth, and fetal growth restriction. The research aims to identify molecular mechanisms and network-level patterns...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $716,587 to Boston Children's Hospital to advance equity in rare disease genomic research. The key objectives are to: Develop and implement a Diversity, Equity, and Inclusion toolkit within the Broad Institute's Rare Genomes Project to improve engagement and participation from historically underrepresented populations in rare disease genomic studies. This will involve...

This Project Grant award of $3,422,481 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a comprehensive genomic resource to characterize novel causes of unexplained recurrent pregnancy loss (RPL).

The key products and services to be delivered under this 5-year award include: 1) leveraging the hospital's large clinical service for RPL and genetic research program to prospectively procure carefully phenotyped trios with fetal cells from spontaneous pregnancy losses and parental DNA/germ cells; 2) integrating a long-read genome sequencing (HiFi-GS) pipeline to identify underexplored genomic variants and epigenomic features linked to RPL; and 3) validating identified molecular variation associated with RPL in thousands of cases from the UK Biobank. The grant aims to consolidate all known molecular tests for genetic disease into a single sequencing run and assess 100 unsolved rare disease families and 100 RPL trios. The genomic resource and research insights generated are expected to spark community-wide research on dozens of RPL-associated genes impacting fetal viability.

Generated 7/8/25, 1:17 PM